FDA grants breakthrough device designation to Tempus’ atrial fibrillation ECG analysis platform, developed in collaboration with Geisinger

24 March 2021 - Tempus today announced that the U.S. FDA has granted the company breakthrough device designation for its ECG ...

Read more →

Biden’s choice and FDA’s loosening standards of evidence

23 March 2021 - The US Food and Drug Administration is widely considered the world’s premier regulator of drugs and devices, ...

Read more →

FDA authorises LetsGetChecked’s home collection coronavirus (COVID-19) test for direct to consumer purchase

24 March 2021 - The direct to consumer test is now authorised by the FDA to sell directly to consumers online ...

Read more →

DoorDash launches on-demand delivery of COVID-19 PCR test collection kits through partnerships with Vault Health and Everlywell

22 March 2021 - New partnerships make same-day delivery of FDA authorised COVID-19 test collection kits widely available to consumers across ...

Read more →

AstraZeneca vaccine trial data questions raised by US drug agency

23 March 2021 - Promising results announced on Monday from AstraZeneca’s American vaccine trials may have relied on an incomplete ...

Read more →

Indian cancer drug manufacturer to pay $50 million for concealing and destroying records in advance of FDA inspection

23 March 2021 - Indian drug manufacturer Fresenius Kabi Oncology was sentenced to pay $50 million in fines and forfeiture ...

Read more →

Novo Nordisk receives refusal to file letter for once weekly semaglutide 2 mg for the treatment of type 2 diabetes

22 March 2021 - Novo Nordisk today announced that the US FDA has issued a refusal to file letter covering the ...

Read more →

Optellum receives FDA clearance for the world’s first AI-powered clinical decision support software for early lung cancer diagnosis

23 March 2021 - Virtual Nodule Clinic empowers clinicians to make optimal clinical decisions in early-stage lung cancer diagnosis and is ...

Read more →

Pacira announces FDA approval of supplemental new drug application for Exparel (bupivacaine liposome injectable suspension) in paediatric patients

22 March 2021 - Exparel is the first and only FDA approved long-acting local analgesic for children aged six and over. ...

Read more →

Zealand Pharma announces FDA approval of Zegalogue (dasiglucagon) injection for the treatment of severe hypoglycaemia in people with diabetes

22 March 2021 - Approval based on results from three pivotal trials in adults and children with diabetes, showing median time ...

Read more →

FDA approves pembrolizumab for oesophageal or GEJ carcinoma

22 March 2021 - Today the FDA approved pembrolizumab (Keytruda, Merck Sharp & Dohme) in combination with platinum and fluoropyrimidine-based chemotherapy ...

Read more →

Oakrum Pharma and Aucta Pharma announce U.S. FDA approval of generic version of Jadenu Sprinkle (deferasirox granules)

22 March 2021 - Oakrum Pharma in collaboration with Aucta Pharmaceuticals announced today the U.S. approval of a generic version of ...

Read more →

FDA authorises first machine learning-based screening device to identify certain biomarkers that may indicate COVID-19 infection

19 March 2021 - Device may be used to identify biomarkers indicative of SARS-CoV-2 infection among certain asymptomatic individuals following a ...

Read more →

Senate narrowly confirms Becerra as health secretary

18 March 2021 - Republican Sen. Susan Collins joined all of the Democrats present in the 50-49 vote. ...

Read more →

Too fast or too slow: is the FDA moving at the right speed?

19 March 2021 - Regardless of President Joe Biden’s choice for the next commissioner of the FDA, the Senate Health, Education, ...

Read more →